~~<i id='DF29E0A1F3'><strike id='DF29E0A1F3'><tt id='DF29E0A1F3'><pre id='DF29E0A1F3'></pre></tt></strike></i>~~

Home» explore» knowledge

knowledge

author：hotspot 2025-09-30 06:41:58 Page View：51128

Senate health committee Chair Bernie Sanders — Sen. Berne Sanders (I-Vt.) Kevin Dietsch/Getty Images

WASHINGTON — Sen. Bernie Sanders (I-Vt.) has a new corporate target: the food industry.

Sanders held a hearing today on diabetes that implicated both the food and drug industries in what the American Diabetes Association estimates is a $413 billion annual cost to the health care system. That’s up 27% over the past six years, he said, and he warned that new weight loss drugs could send health care spending to the stratosphere.

But the food industry received more attention, especially from Sanders, than the drugmakers and drug middlemen.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In 'major milestone,' FDA approves first cell therapy for solid tumors
Next article： 23andMe had bad news about my health. I wish a person had delivered it

explore

Anesthesiologist group: stop taking Ozempic before surgery

EspeciallyinthefirstweeksoftakingdrugslikeOzempic,foodstayslongerinthestomach—aprobleminsurgeries.Ad

Readout Newsletter: Sarepta, Alnylam, and Royalty Pharma

RubyWallauforSTATWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechne

Dobbs anniversary: the lost opportunity of abortion as health care

NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

In diabetes hearing, Sanders takes on a new foe: food makers

Sen.BerneSanders(I-Vt.)KevinDietsch/GettyImagesWASHINGTON—Sen.BernieSanders(I-Vt.)hasanewcorporateta